Safety Alert: Quetiapine

Recall of Seroquel XR (quetiapine fumarate) 50mg Samples

AstraZeneca has issued a nationwide recall of Seroquel XR 50mg Samples provided by a physician in a four tablet blister card. The samples are being recalled because they contain the incorrect Product Insert (Prescribing Information). This recall pertains specifically to NDC 0310-0280-94.

Source: Manufacturer
Publication Date: 2009-Apr-10
Last Updated: 2009-Apr-10

What does this mean?

If have received a sample for Seroquel XR 50mg packaged in a four table blister card, look at the card to locate the NDC number. If your sample is labeled NDC 0310-0280-94, then you likely received the incorrect prescribing information for this product. To obtain a correct version of the prescribing information, you can request a copy from your pharmacist; download a copy at: http://www1.astrazeneca-us.com/pi/seroquelxr.pdf; or request a copy from the manufacturer, AstraZeneca by calling: 1-800-236-9933.

Vist theQuetiapine medication page for more information about Quetiapine.

DISCLAIMER: iGuard is not intended to be a substitute for professional medical advice. iGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the iGuard site and its content is at your own risk. The iGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Bookmark and Share